TREATMENT OF CANCER BY SYSTEMIC ADMINISTRATION OF DBAIT MOLECULES
The present invention relates to the use of a DBait molecules by systemic routes without any combination with an endosomolytic agent. 本发明涉及DBait分子的用途,其不与任何内涵体裂解剂相组合,通过全身性途径使用。
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to the use of a DBait molecules by systemic routes without any combination with an endosomolytic agent.
本发明涉及DBait分子的用途,其不与任何内涵体裂解剂相组合,通过全身性途径使用。 |
---|---|
Bibliography: | Application Number: CN201780014979 |